Clinical laboratories, including ARUP Laboratories, are reviewing newly introduced federal legislation to modernize oversight ...

The chemiluminescence immunoassay (CLIA) market is expected to grow from USD 11.58 billion in 2026 to USD 16.39 billion by 2031, at a CAGR of 7.2%. Key drivers include the rising demand for accurate ...

Nucleic acid amplification Testing (NAT) is expected to minimize the potential risk of transfusion transmitted infections (TTIs) which escaped the detection by serologic screening. Therefore, the aim ...

New regulations under the Clinical Laboratory Improvement Amendments (CLIA) introduced updated proficiency testing (PT) and PT referral rules that are now in effect. Although the regulations became ...

Executive War College to Address, Clinical Laboratories’ and Genetic Testing Firms’ Perfect Storm, involving FDA’s Proposed LDT Rule, Payers Requiring Z-Codes on Genetic Test Claims, and Revisions to ...

Lumos Diagnostics CEO Doug Ward joined Steve Darling from Proactive to discuss the company’s recent achievement of CLIA ...

QuidelOrtho Corporation QDEL recently announced that it has been granted a CLIA Waiver by the FDA, which applies to its new Sofia 2 SARS Antigen+ FIA (fluorescent immunoassay). The Sofia 2 SARS ...

HOUSTON, Feb. 26, 2025 /PRNewswire/ -- Avance Biosciences, a leading provider of high-quality analytical and bioanalytical services for the pharmaceutical industry, is pleased to announce that it has ...

SAN DIEGO, CA - June 24, 2025 (NEWMEDIAWIRE) - Axim Biotechnologies, Inc. (OTCQB: AXIM), a leading developer of rapid diagnostic testing for ocular and systemic conditions, today announced that it has ...

High Expression of FGD3, a Putative Regulator of Cell Morphology and Motility, Is Prognostic of Favorable Outcome in Multiple Cancers In all, 142 (95%) of 150 questionnaires were completed by 38 ...